Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Kim
Peter J Neumann

Showing results (111-120 of 436) with videos related to

Pageof 44
Sort By:
Annals of Internal Medicine|August 29, 2017
A Call for Open-Source Cost-Effectiveness AnalysisJoshua T Cohen, Peter J Neumann, John B Wong
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2009
Understanding the medical and nonmedical value of diagnostic testingDavid W Lee, Peter J Neumann, John A Rizzo
Health Affairs (Project Hope)|November 11, 2008
Medicare's national coverage decisions for technologies, 1999-2007Peter J Neumann, Maki S Kamae, Jennifer A Palmer
The American Journal of Managed Care|August 20, 2016
The impact of formulary drug exclusion policies on patients and healthcare costsJames D Chambers, Pallavi B Rane, Peter J Neumann
The New England Journal of Medicine|August 28, 2014
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY thresholdPeter J Neumann, Joshua T Cohen, Milton C Weinstein
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1]Peter J Neumann, Richard J Willke, Louis P Garrison
Annals of Internal Medicine|April 4, 2018
A Call for Open-Source Cost-Effectiveness AnalysisJoshua T Cohen, Peter J Neumann, John B Wong
The American Journal of Managed Care|September 24, 2016
Mapping US commercial payers' coverage policies for medical interventionsJames D Chambers, Matthew D Chenoweth, Peter J Neumann
The New England Journal of Medicine|October 7, 2005
Medicare and cost-effectiveness analysisPeter J Neumann, Allison B Rosen, Milton C Weinstein
JAMA|December 29, 2016
Updated Recommendations for Cost-effectiveness Studies-ReplyGillian D Sanders, Peter J Neumann, Louise B Russell
Pageof 44

Showing results (111-120 of 436) with videos related to

Sort By:
Pageof 44
Annals of Internal Medicine|August 29, 2017
A Call for Open-Source Cost-Effectiveness AnalysisJoshua T Cohen, Peter J Neumann, John B Wong
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2009
Understanding the medical and nonmedical value of diagnostic testingDavid W Lee, Peter J Neumann, John A Rizzo
Health Affairs (Project Hope)|November 11, 2008
Medicare's national coverage decisions for technologies, 1999-2007Peter J Neumann, Maki S Kamae, Jennifer A Palmer
The American Journal of Managed Care|August 20, 2016
The impact of formulary drug exclusion policies on patients and healthcare costsJames D Chambers, Pallavi B Rane, Peter J Neumann
The New England Journal of Medicine|August 28, 2014
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY thresholdPeter J Neumann, Joshua T Cohen, Milton C Weinstein
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1]Peter J Neumann, Richard J Willke, Louis P Garrison
Annals of Internal Medicine|April 4, 2018
A Call for Open-Source Cost-Effectiveness AnalysisJoshua T Cohen, Peter J Neumann, John B Wong
The American Journal of Managed Care|September 24, 2016
Mapping US commercial payers' coverage policies for medical interventionsJames D Chambers, Matthew D Chenoweth, Peter J Neumann
The New England Journal of Medicine|October 7, 2005
Medicare and cost-effectiveness analysisPeter J Neumann, Allison B Rosen, Milton C Weinstein
JAMA|December 29, 2016
Updated Recommendations for Cost-effectiveness Studies-ReplyGillian D Sanders, Peter J Neumann, Louise B Russell
Pageof 44